FAM193A
gene geneOn this page
Also known as RES4-22
Summary
FAM193A (family with sequence similarity 193 member A, HGNC:16822) is a protein-coding gene on chromosome 4p16.3, encoding Protein FAM193A (P78312). Acts as a positive regulator of p53/TP53 by interacting with p53 repressors MDM2 and MDM4 and destabilizing MDM4 which leads to enhanced p53 transcriptional activity.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 193 total — 1 pathogenic
- MANE Select transcript:
NM_001366318
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16822 |
| Approved symbol | FAM193A |
| Name | family with sequence similarity 193 member A |
| Location | 4p16.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RES4-22 |
| Ensembl gene | ENSG00000125386 |
| Ensembl biotype | protein_coding |
| OMIM | 620037 |
| Entrez | 8603 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 11 protein_coding, 2 retained_intron, 2 nonsense_mediated_decay
ENST00000324666, ENST00000382839, ENST00000502458, ENST00000505311, ENST00000506120, ENST00000506904, ENST00000512465, ENST00000513350, ENST00000513898, ENST00000545951, ENST00000637812, ENST00000931499, ENST00000970595, ENST00000970596, ENST00000970597
RefSeq mRNA: 6 — MANE Select: NM_001366318
NM_001256666, NM_001256667, NM_001256668, NM_001366316, NM_001366318, NM_003704
CCDS: CCDS33943, CCDS58874, CCDS58875, CCDS58876, CCDS93467
Canonical transcript exons
ENST00000637812 — 21 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000854795 | 2639735 | 2639859 |
| ENSE00000854806 | 2659558 | 2659670 |
| ENSE00000854811 | 2659812 | 2660054 |
| ENSE00000854812 | 2662838 | 2662991 |
| ENSE00000854819 | 2663109 | 2663288 |
| ENSE00000854823 | 2672121 | 2672372 |
| ENSE00001080016 | 2690698 | 2690970 |
| ENSE00001080019 | 2694946 | 2695129 |
| ENSE00001080022 | 2689506 | 2689704 |
| ENSE00001164061 | 2646685 | 2646832 |
| ENSE00001266537 | 2693586 | 2693874 |
| ENSE00002073430 | 2630935 | 2631169 |
| ENSE00002084936 | 2625262 | 2625395 |
| ENSE00003478727 | 2716023 | 2716104 |
| ENSE00003658596 | 2699680 | 2700544 |
| ENSE00003677360 | 2696363 | 2696593 |
| ENSE00003756635 | 2657803 | 2657880 |
| ENSE00003792978 | 2596084 | 2596329 |
| ENSE00003794990 | 2626410 | 2626577 |
| ENSE00003795065 | 2536647 | 2537170 |
| ENSE00003800235 | 2731775 | 2732573 |
Expression profiles
Bgee: expression breadth ubiquitous, 269 present calls, max score 94.77.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 25.3501 / max 339.1804, expressed in 1816 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 46620 | 25.1723 | 1816 |
| 46619 | 0.1778 | 69 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 94.77 | gold quality |
| ventricular zone | UBERON:0003053 | 90.14 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.70 | gold quality |
| cortical plate | UBERON:0005343 | 89.06 | gold quality |
| oocyte | CL:0000023 | 88.02 | gold quality |
| ganglionic eminence | UBERON:0004023 | 87.67 | gold quality |
| embryo | UBERON:0000922 | 87.45 | gold quality |
| secondary oocyte | CL:0000655 | 87.07 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.84 | gold quality |
| cartilage tissue | UBERON:0002418 | 86.07 | gold quality |
| right testis | UBERON:0004534 | 85.66 | gold quality |
| tibialis anterior | UBERON:0001385 | 85.62 | silver quality |
| left testis | UBERON:0004533 | 85.49 | gold quality |
| testis | UBERON:0000473 | 85.41 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 85.32 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 85.29 | gold quality |
| cerebellar cortex | UBERON:0002129 | 85.27 | gold quality |
| tendon | UBERON:0000043 | 85.26 | gold quality |
| ileal mucosa | UBERON:0000331 | 85.25 | gold quality |
| cerebellum | UBERON:0002037 | 84.86 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.72 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.65 | gold quality |
| muscle of leg | UBERON:0001383 | 84.56 | gold quality |
| body of uterus | UBERON:0009853 | 84.04 | gold quality |
| popliteal artery | UBERON:0002250 | 83.85 | gold quality |
| tibial artery | UBERON:0007610 | 83.85 | gold quality |
| pituitary gland | UBERON:0000007 | 83.79 | gold quality |
| stromal cell of endometrium | CL:0002255 | 83.74 | gold quality |
| adult organism | UBERON:0007023 | 83.70 | gold quality |
| left ovary | UBERON:0002119 | 83.65 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.73 |
| E-MTAB-7381 | no | 471.62 |
| E-MTAB-7303 | no | 374.44 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
42 targeting FAM193A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4650-5P | 99.98 | 64.69 | 999 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-187-5P | 99.74 | 70.26 | 1404 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-12132 | 99.47 | 68.90 | 1341 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-5580-5P | 99.38 | 66.96 | 1139 |
| HSA-MIR-4999-5P | 99.35 | 69.15 | 926 |
| HSA-MIR-6882-5P | 99.35 | 71.13 | 1206 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-4801 | 98.96 | 69.42 | 2096 |
| HSA-MIR-936 | 98.87 | 70.51 | 1124 |
| HSA-MIR-3190-5P | 98.87 | 64.89 | 1345 |
| HSA-MIR-2276-3P | 98.76 | 67.75 | 1384 |
| HSA-MIR-1537-5P | 98.70 | 68.33 | 999 |
| HSA-MIR-2467-3P | 98.65 | 67.18 | 1969 |
| HSA-MIR-7155-5P | 98.65 | 66.14 | 1290 |
| HSA-MIR-3691-5P | 98.62 | 65.88 | 552 |
| HSA-MIR-4731-3P | 98.56 | 68.60 | 1860 |
| HSA-MIR-4718 | 98.55 | 68.61 | 814 |
| HSA-MIR-499B-5P | 98.35 | 68.39 | 988 |
Literature-anchored findings (GeneRIF, showing 1)
- FAM193A is a positive regulator of p53 activity. (PMID:36897777)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam193a | ENSDARG00000102787 |
| mus_musculus | Fam193a | ENSMUSG00000037210 |
| rattus_norvegicus | Fam193a | ENSRNOG00000013832 |
| drosophila_melanogaster | CG7518 | FBGN0038108 |
Paralogs (1): FAM193B (ENSG00000146067)
Protein
Protein identifiers
Protein FAM193A — P78312 (reviewed: P78312)
Alternative names: Protein IT14
All UniProt accessions (4): P78312, A0A1B0GVL4, D6RFZ4, E7EUR8
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a positive regulator of p53/TP53 by interacting with p53 repressors MDM2 and MDM4 and destabilizing MDM4 which leads to enhanced p53 transcriptional activity.
Subunit / interactions. Component of a ternary complex composed of FAM193A, MDM4 and MDM2; interaction of FAM193A with MDM4 is mediated by the MDM4 RING-type zinc finger and results in MDM4 destabilization. Although FAM193A interacts with MDM4 and MDM2, it does not affect formation of the p53-MDM2-MDM4 transcriptional repressor complex.
Subcellular location. Nucleus. Cytoplasm.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the FAM193 family.
Isoforms (7)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P78312-7 | 1 | yes |
| P78312-1 | 2, RES4-22B | |
| P78312-2 | 3, RES4-22A | |
| P78312-3 | 4, RES4-22C | |
| P78312-4 | 5, RES4-22D | |
| P78312-5 | 6 | |
| P78312-6 | 7 |
RefSeq proteins (6): NP_001243595, NP_001243596, NP_001243597, NP_001353245, NP_001353247, NP_003695 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029717 | FAM193 | Family |
| IPR031802 | FAM193_C | Domain |
Pfam: PF15914
UniProt features (38 total): compositionally biased region 10, splice variant 9, region of interest 8, modified residue 5, coiled-coil region 3, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P78312-F1 | 51.17 | 0.08 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (5): 584, 674, 933, 1420, 1435
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 85 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_UP, DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN, HSIAO_HOUSEKEEPING_GENES, CAGCTG_AP4_Q5, GOBP_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, ONKEN_UVEAL_MELANOMA_UP, NF1_Q6_01, BLALOCK_ALZHEIMERS_DISEASE_UP, DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN, chr4p16, GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, LXR_Q3
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CHCHD4 | SSNA1 | psi-mi:“MI:0914”(association) | 0.640 |
| H3C13 | FAM193A | psi-mi:“MI:0915”(physical association) | 0.400 |
| FAM193A | TCOF1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| EGLN3 | FAM168B | psi-mi:“MI:0914”(association) | 0.350 |
| FGF11 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.350 |
| SYCE1 | RABGAP1L | psi-mi:“MI:0914”(association) | 0.350 |
| MDM4 | TP73 | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA10 | KANSL1L | psi-mi:“MI:0914”(association) | 0.350 |
| AGGF1 | BLTP3B | psi-mi:“MI:2364”(proximity) | 0.270 |
| SRSF7 | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ANKRD28 | TBKBP1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| FAM193A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (82): FAM193A (Affinity Capture-MS), FAM193A (Affinity Capture-MS), FAM193A (Affinity Capture-RNA), FAM193A (Affinity Capture-MS), FAM193A (Affinity Capture-MS), FAM193A (Affinity Capture-RNA), TCOF1 (Proximity Label-MS), FAM193A (Proximity Label-MS), FAM193A (Proximity Label-MS), FAM193A (Proximity Label-MS), FAM193A (Proximity Label-MS), FAM193A (Proximity Label-MS), FAM193A (Proximity Label-MS), FAM193A (Proximity Label-MS), FAM193A (Proximity Label-MS)
ESM2 similar proteins: A0JLT2, A4QNZ7, A5PK23, B1AZP2, F5HSE3, O60293, O75420, O95402, P61129, P78312, P97839, Q03111, Q07FY3, Q08C81, Q08DM1, Q174D3, Q1LVC2, Q32NP7, Q3T044, Q4G0F8, Q5EAY2, Q5F368, Q5R8Q8, Q5U2R6, Q6DD45, Q6DRL8, Q6PEI3, Q7TN02, Q80Z38, Q8C1B1, Q8C1S0, Q8CFT2, Q8CGI1, Q8IVL1, Q8K4J6, Q90YL3, Q90YY5, Q969V6, Q96A73, Q99MR1
Diamond homologs: A7MB40, P78312, Q3U2K0, Q8CGI1, Q96PV7, Q09FC8, Q5H9K5, Q68CZ1, Q8N9N2, Q8TDM0, Q96J02, Q96MD7, A0A096LPI5, A2RRD8, A6NHJ4, A6NJG6, P0CJ79, P17035, P51522, P51957, Q08AN1, Q0VGE8, Q3MIS6, Q5HY98, Q5R8X1, Q5RER9, Q5VIY5, Q6PDB4, Q6ZN06, Q6ZN19, Q6ZNA1, Q6ZNG1, Q76KX8, Q7L2R6, Q86XN6, Q86XU0, Q8N4W9, Q8N782, Q8N823, Q8N8H1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
193 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 160 |
| Likely benign | 5 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 814518 | GRCh37/hg19 4p16.3(chr4:68345-2786584)x1 | Pathogenic |
SpliceAI
4623 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:2626408:A:AG | acceptor_gain | 1.0000 |
| 4:2626409:G:GG | acceptor_gain | 1.0000 |
| 4:2626409:GA:G | acceptor_gain | 1.0000 |
| 4:2626409:GAGA:G | acceptor_gain | 1.0000 |
| 4:2626409:GAGAA:G | acceptor_gain | 1.0000 |
| 4:2626552:G:GT | donor_gain | 1.0000 |
| 4:2626555:G:GT | donor_gain | 1.0000 |
| 4:2626573:GA:G | donor_gain | 1.0000 |
| 4:2626574:A:G | donor_gain | 1.0000 |
| 4:2626574:ATAGG:A | donor_loss | 1.0000 |
| 4:2626575:TAGG:T | donor_loss | 1.0000 |
| 4:2626576:AGGTA:A | donor_loss | 1.0000 |
| 4:2626579:T:G | donor_loss | 1.0000 |
| 4:2630933:A:AG | acceptor_gain | 1.0000 |
| 4:2630934:G:GG | acceptor_gain | 1.0000 |
| 4:2631166:TCTGG:T | donor_loss | 1.0000 |
| 4:2631167:CTGG:C | donor_loss | 1.0000 |
| 4:2631168:TGGT:T | donor_loss | 1.0000 |
| 4:2631169:GGT:G | donor_loss | 1.0000 |
| 4:2631170:G:GG | donor_gain | 1.0000 |
| 4:2631170:GTAA:G | donor_loss | 1.0000 |
| 4:2631171:T:G | donor_loss | 1.0000 |
| 4:2638280:G:GT | donor_gain | 1.0000 |
| 4:2639719:A:AG | acceptor_gain | 1.0000 |
| 4:2639734:GGA:G | acceptor_gain | 1.0000 |
| 4:2639856:TCAGG:T | donor_loss | 1.0000 |
| 4:2639857:CAGG:C | donor_loss | 1.0000 |
| 4:2639858:AGG:A | donor_loss | 1.0000 |
| 4:2639859:GGTA:G | donor_loss | 1.0000 |
| 4:2639860:GT:G | donor_loss | 1.0000 |
AlphaMissense
10025 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:2639768:T:A | W67R | 1.000 |
| 4:2639768:T:C | W67R | 1.000 |
| 4:2659852:T:C | C224R | 1.000 |
| 4:2695091:T:A | C789S | 1.000 |
| 4:2695091:T:C | C789R | 1.000 |
| 4:2695092:G:A | C789Y | 1.000 |
| 4:2695092:G:C | C789S | 1.000 |
| 4:2695092:G:T | C789F | 1.000 |
| 4:2695093:C:G | C789W | 1.000 |
| 4:2695097:T:A | C791S | 1.000 |
| 4:2695097:T:C | C791R | 1.000 |
| 4:2695098:G:A | C791Y | 1.000 |
| 4:2695098:G:C | C791S | 1.000 |
| 4:2695099:C:G | C791W | 1.000 |
| 4:2695100:T:C | C792R | 1.000 |
| 4:2695101:G:A | C792Y | 1.000 |
| 4:2695102:C:G | C792W | 1.000 |
| 4:2695106:T:A | C794S | 1.000 |
| 4:2695106:T:C | C794R | 1.000 |
| 4:2695107:G:A | C794Y | 1.000 |
| 4:2695107:G:C | C794S | 1.000 |
| 4:2695107:G:T | C794F | 1.000 |
| 4:2695108:C:G | C794W | 1.000 |
| 4:2695112:T:C | F796L | 1.000 |
| 4:2695114:C:A | F796L | 1.000 |
| 4:2695114:C:G | F796L | 1.000 |
| 4:2695115:T:C | F797L | 1.000 |
| 4:2695116:T:G | F797C | 1.000 |
| 4:2695117:T:A | F797L | 1.000 |
| 4:2695117:T:G | F797L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000055890 (4:2566417 C>T), RS1000071833 (4:2540720 G>A), RS1000101762 (4:2652139 C>G), RS1000106789 (4:2581675 T>C), RS1000107258 (4:2618911 T>C), RS1000110632 (4:2641601 G>A), RS1000111842 (4:2723779 G>A), RS1000114622 (4:2718634 G>A), RS1000137275 (4:2640177 A>G), RS1000141798 (4:2689045 A>G), RS1000145079 (4:2713415 A>G), RS1000156675 (4:2610662 C>A), RS1000181737 (4:2602667 T>C), RS1000223402 (4:2567139 G>A), RS1000225100 (4:2537551 C>A,G,T)
Disease associations
OMIM: gene MIM:620037 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005141_49 | Cognitive ability (MTAG) | 4.000000e-08 |
| GCST005142_51 | Cognitive ability | 2.000000e-06 |
| GCST005316_147 | Intelligence (MTAG) | 7.000000e-10 |
| GCST005759_7 | Dimensional psychopathology (Social) | 4.000000e-07 |
| GCST006269_698 | General cognitive ability | 1.000000e-09 |
| GCST006624_120 | Systolic blood pressure | 5.000000e-18 |
| GCST007267_44 | Systolic blood pressure | 1.000000e-14 |
| GCST007269_34 | Pulse pressure | 1.000000e-12 |
| GCST007576_220 | Chronotype | 2.000000e-08 |
| GCST009508_1 | Diastolic blood pressure | 9.000000e-07 |
| GCST011956_79 | Systemic lupus erythematosus | 1.000000e-08 |
| GCST90002382_590 | Eosinophil percentage of white cells | 3.000000e-10 |
EFO canonical traits (8, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
| EFO:0004784 | self reported educational attainment |
| EFO:0009100 | social domain measurement |
| EFO:0006335 | systolic blood pressure |
| EFO:0005763 | pulse pressure measurement |
| EFO:0008328 | chronotype measurement |
| EFO:0006336 | diastolic blood pressure |
| EFO:0007991 | eosinophil percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| Cisplatin | affects cotreatment, decreases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| Cadmium Chloride | decreases expression, increases abundance | 2 |
| FR900359 | affects phosphorylation | 1 |
| dicrotophos | increases expression | 1 |
| alpha-pinene | affects cotreatment, increases expression, increases abundance | 1 |
| bisphenol A | decreases methylation | 1 |
| butyraldehyde | decreases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| coumarin | increases phosphorylation | 1 |
| methacrylaldehyde | affects cotreatment, increases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acrolein | increases expression, increases abundance, affects cotreatment | 1 |
| Air Pollutants | affects cotreatment, increases abundance, increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Caffeine | affects phosphorylation | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects cotreatment, increases expression, increases abundance | 1 |
| Quercetin | increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Dihydrotestosterone | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.